SK bioscience avian influenza vaccine

The SK bioscience avian influenza vaccine is a preclinical-stage vaccine candidate designed to induce protective immunity against avian influenza virus strains, commonly referred to as bird flu. Developed by SK bioscience, the vaccine is intended to stimulate the immune system to recognize and neutralize viral components of avian influenza, thereby preventing infection in humans. This program leverages the developer's specialized vaccine technology platforms, which include established cell culture-based manufacturing processes used in their approved seasonal influenza vaccines. The development of this vaccine is part of a broader strategy to prepare for potential pandemic threats posed by highly pathogenic avian influenza viruses.

Other names

avian influenza vaccinebird flu vaccine